PNN DigitalPNN Digital
    Facebook Twitter Instagram
    Friday, August 1
    Trending
    • India’s Conscious Consumers Choose ACTIZEET as the Best Essential Oil Brand
    • Sid Sriram Announces His First-Ever India Tour in 2025 – A Landmark Musical Homecoming Across Bengaluru, Chennai, and Hyderabad
    • AGL To Strengthen Its Hold in Building Materials Sector Supporting Its Vision for Future Growth
    • Kumar Sanu’s Musical Legacy Echoes in Sanjay Bedia’s Latest Teaser Launch of ‘Haay Mera Dil’
    • Best Practices for Integrating Aptitude Tests into Your Recruitment Workflow
    • Jyoti Global Plast Limited to raise up to Rs. 35.44 crore from Public Issue; IPO opens on August 4
    • Fredun Pharmaceuticals Net Profit Rises 64% YoY in Q1 FY26
    • Born to the Voice of Sonu Nigam: Fan Couple Schedule Baby’s Birth to Match Singer’s 52nd Birthday – Youngest listener launches his new song “Kahani Meri” – Distributed by Global Music Junction
    Submit News
    PNN DigitalPNN Digital
    Subscribe
    • Home
    • News
    • Business
    • Entertainment
    • National
    • Lifestyle
    • More
      • Sports
      • Health
      • Finance
      • Education
    PNN DigitalPNN Digital
    Home»Business

    Fredun Pharmaceuticals Net Profit Rises 64% YoY in Q1 FY26

    PNN NewsdeskPNN Newsdesk Business 2 Mins Read
    Fredun
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Mumbai (Maharashtra) [India], July 31: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and Animal Healthcare Products, has reported its Unaudited financials for Q1 FY26.

    Key Financial Highlights 

    Particulars (₹ Cr) Q1 FY26 Q1 FY25 YoY
    Total Income 119.86 78.81 52.08%
    EBITDA 16.99 10.48 62.15%
    EBITDA Margin (%) 14.18 13.30 88 BPS
    Net Profit 6.77 4.13 63.82%
    Net Profit Margin (%) 5.64 5.24 40 BPS
    Diluted EPS (₹) 14.33 8.79 63.03%

    Commenting on the financial performance Mr. Fredun Medhora, Managing Director, said “We are pleased to report a strong start to FY26 with a significant year-on-year growth in net profit and healthy improvement across all key financial metrics. Our performance reflects the successful execution of our growth strategy and the continued demand for our diversified portfolio across domestic and international markets. Our generics portfolio continues to strengthen, with over 1,200 products currently under registration. Our current order book stands at over ₹200 crore, providing strong revenue visibility and momentum for the upcoming quarters.

    We have entered the organized pet care market with the acquisition of a controlling stake in One Pet Stop through our subsidiary FRPL, giving us access to a loyal customer base and a tech-enabled, doorstep grooming service. This move complements our premium Freossi pet care range and strengthens our vision to grow as a holistic player in India’s rapidly expanding pet wellness space.

    The pharmaceutical and healthcare industry continues to see robust demand driven by increasing health awareness, focus on affordable care, and supportive regulatory frameworks. With our growing presence in generics, cosmeceuticals, nutraceuticals, mobility aids, and animal health products, we are well-positioned to capitalize on these opportunities. Looking ahead, we remain committed to enhancing value through consistent performance, product innovation, and expanding our global reach.”

    Q1 FY26 Key Business Highlights

    Upgrade in Credit Rating
    • Rating Upgrade:
    • Long-term rating upgraded to IVR BBB/Stable (from IVR BBB-/Stable)
    • Assigned IVR BBB/Stable / IVR A3+ for long/short-term facilities
    • Total amount rated: ₹139.64 Cr
    Acquisition of One Pet Stop
    • Entity Involved: Fredun Retail Pvt. Ltd. (FRPL), a wholly owned subsidiary.
    • Acquisition: FPRL acquires controlling stake in One Pet Stop Pvt. Ltd.

    If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

    64% YoY fredun pharmaceuticals Net Profit Rises
    PNN Newsdesk

    Keep Reading

    India’s Conscious Consumers Choose ACTIZEET as the Best Essential Oil Brand

    Sid Sriram Announces His First-Ever India Tour in 2025 – A Landmark Musical Homecoming Across Bengaluru, Chennai, and Hyderabad

    AGL To Strengthen Its Hold in Building Materials Sector Supporting Its Vision for Future Growth

    Kumar Sanu’s Musical Legacy Echoes in Sanjay Bedia’s Latest Teaser Launch of ‘Haay Mera Dil’

    Best Practices for Integrating Aptitude Tests into Your Recruitment Workflow

    Jyoti Global Plast Limited to raise up to Rs. 35.44 crore from Public Issue; IPO opens on August 4

    Recent Posts
    • India’s Conscious Consumers Choose ACTIZEET as the Best Essential Oil Brand
    • Sid Sriram Announces His First-Ever India Tour in 2025 – A Landmark Musical Homecoming Across Bengaluru, Chennai, and Hyderabad
    • AGL To Strengthen Its Hold in Building Materials Sector Supporting Its Vision for Future Growth
    • Kumar Sanu’s Musical Legacy Echoes in Sanjay Bedia’s Latest Teaser Launch of ‘Haay Mera Dil’
    • Best Practices for Integrating Aptitude Tests into Your Recruitment Workflow

    India’s Conscious Consumers Choose ACTIZEET as the Best Essential Oil Brand

    31/07/2025

    Sid Sriram Announces His First-Ever India Tour in 2025 – A Landmark Musical Homecoming Across Bengaluru, Chennai, and Hyderabad

    31/07/2025

    AGL To Strengthen Its Hold in Building Materials Sector Supporting Its Vision for Future Growth

    31/07/2025

    Kumar Sanu’s Musical Legacy Echoes in Sanjay Bedia’s Latest Teaser Launch of ‘Haay Mera Dil’

    31/07/2025

    Best Practices for Integrating Aptitude Tests into Your Recruitment Workflow

    31/07/2025

    Jyoti Global Plast Limited to raise up to Rs. 35.44 crore from Public Issue; IPO opens on August 4

    31/07/2025
    Facebook Instagram Twitter
    • Legal Disclaimer
    • Privacy Policy
    • Contact Us
    • About Us
    © 2025 PNN Digital. Designed by Primex Media Services.

    Type above and press Enter to search. Press Esc to cancel.